4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-054731
President and CEO sold 20,000 shares at $4.34 ($86,800)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin President and CEO | 2023-11-07 | Sale | −20,000 | $4.34 | $86,800 | 5,275,796 | D |
| Open-market sales · 20,000 sh · avg $4.34 · $86,800 | |||||||
Loading xslF345X05/doc4.xml…